Ono Pharmaceutical Co Ltd (OPHLY)
4.43
-0.10
(-2.21%)
USD |
OTCM |
Sep 27, 15:59
Ono Pharmaceutical Total Assets (Quarterly): 6.037B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.037B |
| December 31, 2023 | 6.323B |
| September 30, 2023 | 5.997B |
| June 30, 2023 | 6.021B |
| March 31, 2023 | 6.623B |
| December 31, 2022 | 6.335B |
| September 30, 2022 | 5.572B |
| June 30, 2022 | 5.595B |
| March 31, 2022 | 6.056B |
| December 31, 2021 | 6.431B |
| September 30, 2021 | 6.904B |
| June 30, 2021 | 6.720B |
| March 31, 2021 | 6.757B |
| December 31, 2020 | 6.971B |
| September 30, 2020 | 6.688B |
| June 30, 2020 | 6.306B |
| March 31, 2020 | 6.231B |
| December 31, 2019 | 6.054B |
| September 30, 2019 | 5.948B |
| June 30, 2019 | 5.941B |
| March 31, 2019 | 5.908B |
| December 31, 2018 | 5.704B |
| September 30, 2018 | 5.631B |
| June 30, 2018 | 5.598B |
| March 31, 2018 | 5.733B |
| Date | Value |
|---|---|
| December 31, 2017 | 5.288B |
| September 30, 2017 | 5.125B |
| June 30, 2017 | 5.153B |
| March 31, 2017 | 5.523B |
| December 31, 2016 | 5.016B |
| September 30, 2016 | 5.510B |
| June 30, 2016 | 5.257B |
| March 31, 2016 | 4.808B |
| December 31, 2015 | 4.410B |
| September 30, 2015 | 4.309B |
| June 30, 2015 | 4.302B |
| March 31, 2015 | 4.370B |
| December 31, 2014 | 4.232B |
| September 30, 2014 | 4.456B |
| June 30, 2014 | 4.824B |
| March 31, 2014 | 4.724B |
| December 31, 2013 | 4.515B |
| September 30, 2013 | 4.709B |
| June 30, 2013 | 4.615B |
| March 31, 2013 | 5.045B |
| December 31, 2012 | 5.044B |
| September 30, 2012 | 5.539B |
| June 30, 2012 | 5.445B |
| March 31, 2012 | 5.601B |
| December 31, 2011 | 5.428B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.572B
Minimum
Sep 2022
6.971B
Maximum
Dec 2020
6.293B
Average
6.306B
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 100.84B |
| Nxera Pharma Co Ltd | 972.39M |
| PeptiDream Inc | 595.81M |
| Healios KK | 110.68M |
| AnGes Inc | 171.98M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 760.22M |
| Shareholders Equity (Quarterly) | 5.239B |
| Current Ratio | 3.991 |